EU Commission Approves LORVIQUA® (LORLATINIB) For Adult Patients With Non-Small Cell Lung Cancer
The FINANCIAL -- Pfizer Inc. these days announced that the European Commission (EC) granted conditional marketing authorization for LORVIQUA® (lorlatinib, available ...
